Christina Lake Cannabis Corp
CNSX:CLC
Canada / Healthcare / Pharmaceuticals
Exchange Data
Hide this widget
Price
0.05 CAD
Day change
0.00 (0.00%)
52-week range
0.03 - 0.070
6:00 AM - Closed
Summary of Christina Lake Cannabis Corp
Hide this widget
Christina Lake Cannabis Corp. engages in the research and development, cultivation, processing, production, and sale license of cannabis in British Co...
Latest Report
Oct 29, 2021Next Earnings
Mar 28, 2025
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Years
10 Years
0.00 (0.00%)
Data Explorer
Hide this widget
Search metric that you want to observe. Create your own widget, customise and rearrange metrics
| Metric Name | Value | Trend |
|---|---|---|
| Dividend Yield | 0.0% | |
| P/E Ratio | 13.0x | |
| Revenue | 13.61 M | |
| Net Income to Company | 864.995 K |
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| CLC | Peers | Sector | |
|---|---|---|---|
Market Cap | 11.266 M | 10.812 M | 95.032 M |
Price % of 52 Week High | 71.4% | 42.1% | 62.8% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | -53.1% | 0.0% | -0.7% |
1 Year Price Total Return | 25.0% | -33.3% | -11.0% |
Beta (5 Year) | -0.60 | 0.64 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
0.05
Upside
1.7%
Uncertainty
MED
Spread
0.03 - 0.06
Market Range
52 weeks
C$0
C$0
C$0.050
Analyst Targets
0 analysts
-
Investing Models
C$0
C$0
C$0.051
Financial Health
Health Details
Hide this widget
Financial Health for Christina Lake Cannabis is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Great Performance
▼
▼
Financial Models for Christina Lake Cannabis Corp
Model Gallery
Hide this widget
| DuPont ROE AnalysisView Updated 1 day ago |
| 10Y Historical FinancialsView Updated 1 day ago |
| 5Y Historical FinancialsView Updated 1 day ago |
| EV / EBIT MultiplesView Updated 4 hours ago |
| EV / EBITDA MultiplesView Updated 4 hours ago |
| P/E MultiplesView Updated 4 hours ago |
| Price / Book MultiplesView Updated 4 hours ago |
| Price / Sales MultiplesView Updated 4 hours ago |
| EV / Revenue MultiplesView Updated 4 hours ago |
| CAPM WACC ModelView Updated 11 hours ago |
| 10Y DCF EBITDA ExitView Updated 4 hours ago |
| 10Y DCF Revenue ExitView Updated 4 hours ago |
| 10Y DCF Growth ExitView Updated 4 hours ago |
| 5Y DCF EBITDA ExitView Updated 4 hours ago |
| 5Y DCF Revenue ExitView Updated 4 hours ago |
| 5Y DCF Growth ExitView Updated 4 hours ago |
| Earnings Power ValueView Updated 4 hours ago |
Historical Financials
Full Financials
Hide this widget
| (CAD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Nov-22 | Nov-23 | Nov-24 | Nov-23 | Nov-24 |
| Income Statement | |||||
| Revenue | 10 | 12 | 14 | 2.84 | 3.96 |
| Operating Income | (1.23) | (0.88) | 3.32 | (2.26) | 0.21 |
| Net Profit | (2.03) | (4.13) | 0.86 | (4.63) | (0.62) |
| Diluted EPS | -0.016 | -0.032 | 0.0066 | -0.035 | -0.0047 |
| EBITDA | (0.91) | (0.45) | 3.77 | (2.17) | 0.30 |
| Balance Sheet | |||||
| Cash & ST Invest. | 1.84 | 1.47 | 1.85 | 1.47 | 1.85 |
| Current Assets | 9.52 | 10 | 14 | 10 | 14 |
| Total Assets | 19 | 16 | 23 | 16 | 23 |
| Current Liabilities | 5.83 | 4.00 | 6.27 | 4.00 | 6.27 |
| Total Liabilities | 7.66 | 8.50 | 13 | 8.50 | 13 |
| Total Equity | 11 | 7.46 | 11 | 7.46 | 11 |
| Total Debt | 6.45 | 6.15 | 10 | 6.15 | 10 |
| Cash Flow Statement | |||||
| Cash Flow Operations | 1.18 | 1.38 | 0.22 | 0.05 | 0.51 |
| Cash From Investing | (0.79) | (0.57) | (4.47) | (0.02) | (0.32) |
| Cash From Financing | 0.37 | (1.15) | 4.59 | (0.29) | 0.79 |
| Free Cash Flow | 0.39 | 0.78 | (4.13) | 0.00 | 0.30 |
Analyst Notes
March 24, 2025
Hide this widget